Viewing StudyNCT04629781



Ignite Creation Date: 2024-05-06 @ 3:24 PM
Last Modification Date: 2024-10-26 @ 1:49 PM
Study NCT ID: NCT04629781
Status: TERMINATED
Last Update Posted: 2023-07-27
First Post: 2020-10-22

Brief Title: Open-label Dose Escalation Phase 1b Trial of a New Micellar Docetaxel Compound in Patients With mCRPC
Sponsor: Swiss Group for Clinical Cancer Research
Organization: Swiss Group for Clinical Cancer Research

Conditions & Keywords Data

Conditions:
Name
Metastatic Castration-resistant Prostate Cancer
Keywords:
Name View
Docetaxel View
metastatic castration-resistant prostate cancer View
micellar docetaxel compound View
anti-cancer agent View
Docecal View